Xue Guan

Nov 16, 2023 | onlinelibrary.wiley.com | Yiru Wang |Can Wang |Xue Guan |Ying Ma

1 Introduction Endometrial cancer (EC) is a highly prevalent form of gynecological malignancy, accounting for over 4 10 000 new diagnoses and 9 7000 deaths globally in 2020.[1, 2] Effective and specific biomarkers for EC require in-depth investigation given their uncertainty and elusiveness. Currently, the main treatment options for EC patients include surgical resection, radiotherapy, and chemotherapy.